期刊文献+

喉鳞癌中CDK2对细胞周期的影响及其意义 被引量:3

Effects of CDK2 on cell cycle in laryngeal squamous cell carcinoma and its clinical significance
下载PDF
导出
摘要 目的探讨喉鳞癌组织CDK2激酶表达与肿瘤细胞增殖之间的关系。方法取手术中获得的50例喉鳞癌组织,12例非典型增生组织和30例声带息肉组织,用免疫组化的方法检测CDK2与PCNA的表达;用流式细胞术检测喉鳞癌组织细胞周期比率。结果在喉鳞癌组织中CDK2与PCNA的阳性率表达分别为68.0%和86.0%,显著高于声带息肉组织(P<0.05);并且CDK2的表达与临床分期、病理分级、淋巴转移密切相关,与患者的年龄、性别和原发部位无关。结论喉鳞癌中CDK2过度表达可能与肿瘤细胞增殖异常密切相关。在诊断和治疗喉鳞癌中,CDK2可能是一个有重要作用的指标。 Objective To investigate the role of CDK2 in cell proliferation in laryngeal squamous cell carcinoma(LSCC). Methods The expression of CDK2 protein and proliferating cell nuclear antigen(PCNA)was analyzed in 50 specimens of LSCC,12 specimens of atypical hyperplasia and 30 specimens of vocal cord polyp obtained during operation by immunohistochemical method.The ratio of cell cycle was determined in LSCC using flow cytometry. Results The positive rates of CDK2 and PCNA in LSCC were 68.0%(34/50) and 86.0%(43/50),significantly higher than those in the vocal cord polyp(P〈0.05).Expression of CDK2 in LSCC was positively related with expression of PCNA and cell proliferation.CDK2 expression was closely related with tumor grade,pathological grade and lymphatic metastasis(P〈0.05),but not with primary site of LSCC,gender and age. Conclusion The results indicate that overexpression of CDK2 may be strongly correlated with abnormal proliferation in LSCC,and it may be an important marker in the diagnosis and treatment of LSCC.
作者 刘荣 皇甫辉
出处 《山西医科大学学报》 CAS 2008年第5期433-436,F0003,共5页 Journal of Shanxi Medical University
关键词 喉鳞癌 细胞周期 CDK2 增殖细胞核抗原 增殖 laryngeal squamous cell carcinoma cell cycle CDK2 proliferating cell nuclear antigen proliferation
  • 相关文献

参考文献11

  • 1Stearns T. Centrosome duplication. A centriolar pas de deux[J ]. Cell, 2001,105(4) :417 - 420.
  • 2Mayor T, Meraldi P, Stierhof YD. Protein kinases in control of the centrosome cycle[J ]. FEBS Lett, 1999,452 (1 - 2):92 - 95.
  • 3Bravo R. Synthesis of the nuclear protein cyclin(PCNA)and its relationship with DNA replication [ J ]. Exp Cell Res, 1986, 163 (2) :287 - 293.
  • 4Mihara M, Shintani S, Nakahara Y, et al. Overexpression of CDK2 is a prognostic indicator of oral cancer progression[J]. Jpn J Cancer Res,2001,92(3) :352 - 360.
  • 5Takasaki Y, Kaneda K, Takeuchi K, et al. Analysis of the structure of proteasome-proliferating cell nuclear antigen(PCNA)multiprotein complex and its autoimmtme response in Lupus patients [J]. Ann N Y Acad Sci,2003,987:316-318.
  • 6Konno S, Takebayashi Y, Aib M, et al. Clincopathological and proggnostic significance of thymicline phosphorylase and proliferating cell nuclear antigen in gastric carcinoma[J]. Cancer Lett, 2001,166 (1) : 103 - 111.
  • 7Kayaselcuk F, Zorludemir S, Gumurduhu D, et al. PCNA and Ki-67 in central nervous system tumor:correlation with the histological type and grade[J].J Neurooncol,2002,57(2) :115.
  • 8Shang S, Takai N, Nishida M, et al. CaMKIV expression is associated with clinical stage and PCNA-labeling index in endometrial carcinoma[J]. Int J Mol Med,2003,11(2) : 181.
  • 9Choi HJ,Jung IK,Kim SS, et al. Proliferating cell nuclear antigen expression and its relationship to malignancy poteritial in invasive coloreetal carcinomas [ J ]. Dis Colon Rectum, 1997, 40 (1):51-59.
  • 10李丽,齐凤英,左连富,李萍,王辉.Cyclin E、CDK_2和p21^(WAF1)在食管上皮癌变过程中的表达及意义[J].肿瘤,2005,25(2):158-162. 被引量:13

二级参考文献1

共引文献12

同被引文献20

  • 1任秀莲,魏琦峰,周春山,钟世安,董朝青.沉淀吸附法提取苦丁茶中的熊果酸[J].中南大学学报(自然科学版),2004,35(4):599-603. 被引量:23
  • 2Yao Chen,Yi-Zeng Zhang,Zong-Guang Zhou,Gang Wang,Zeng-Ni Yi.Identification of differently expressed genes in human colorectal adenocarcinoma[J].World Journal of Gastroenterology,2006,12(7):1025-1032. 被引量:10
  • 3Ferlay J, Shin H R, Bray F, et al. Estimates of worldwide hurden of cancer in 2008: GLOBOCAN 2008 [J]. IntJ Cancer, 2010, 127:2893 - 2917.
  • 4Malumbres M, Barbacid M. Cell cycle kinases in cancer[J]. Curr Opin Genet Dev, 2007, 17 (1): 60 -65.
  • 5Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm[J]. Nature Reviews Cancer, 2009 (9): 153-166.
  • 6Xu L, Wang C H, Wen Z K, et al. Selective up- regulation of CDK2 is critical for TLR9 signaling stimulated proliferation of human lung cancer cell [J]. Immunoligy Letters, 2010, 127(2): 93-99.
  • 7Dobashi Y, Shoji M, Jiang S X, et al. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas[J]. American Journal of Pathology, 1998 (3): 963-972.
  • 8Pino M S, Chung D C. The Chromosomal insta bility pathway in colon cancer [J]. Gastroenterology, 2010, 138(6): 2059-2072.
  • 9Xu L, Wang C H, Wen Z K, et al. Selective up- regulation of CDK2 is critical for TLR9 signaling stimulated proliferation of human lung cancer cell [J]. Immunology Letters, 2010, 127(2): 93-99.
  • 10Soffar A, Storch K, Aleem E, et al. CDK2 knockdown enhances head and neck cancer cell radiosensitivity [J]. International Journal of Radiation Biology, 2013, 89(7): 523-531.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部